AI assistant
Sending…
SYNAPTICS Inc — Director's Dealing 2013
Sep 27, 2013
31479_dirs_2013-09-27_30a4c40b-2765-47ce-a351-a2507b8f14a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNAPTICS INC (SYNA)
CIK: 0000817720
Period of Report: 2013-09-25
Reporting Person: Swearingen Stan A Jr (SVP & Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-25 | Common Stock | M | 1000 | $23.16 | Acquired | 18422 | Direct |
| 2013-09-25 | Common Stock | M | 6500 | $32.22 | Acquired | 24922 | Direct |
| 2013-09-25 | Common Stock | S | 7500 | $44.00 | Disposed | 17422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-25 | Employee Stock Options (Right to Buy) | $23.16 | M | 1000 | Disposed | 2019-10-31 | Common Stock (1000) | Direct |
| 2013-09-25 | Employee Stock Options (Right to Buy) | $23.22 | M | 6500 | Disposed | 2018-10-03 | Common Stock (6500) | Direct |
Footnotes
F1: The shares were sold pursuant to a 10b5-1 Sales Plan dated May 17, 2013.
F2: 1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the last day of each month following the date of grant until fully vested on October 31, 2015.
F3: 1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 3rd day of each month following the October 3, 2011 date of grant.
More from SYNAPTICS Inc
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18